Yong Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yong Tang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
BaoLi Xu
Emergency Department, Chengdu Second People's Hospital, Chengdu, Sichuan, China
1 shared publicationSining Chen
Department of Nephrology, The Second People’s Hospital of Baoshan City, Baoshan, China
1 shared publication- Wei Chen
Institute of Electromagnetics and Acoustics and Key Laboratory of Electromagnetic Wave Science and Detection Technology Xiamen University Xiamen Fujian 361005 China
1 shared publication Wenkai Cai
Zhenjiang First Foreign Language School, Zhenjiang, China
1 shared publication- XiaoJia Luo
Emergency Department, Chengdu Second People's Hospital, Chengdu, Sichuan, China
1 shared publication - YanZhang Shu
Emergency Department, Chengdu Second People's Hospital, Chengdu, Sichuan, China
1 shared publication
Latest Publications
- 10 July 2025
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 21 (7) , 1918-1930
Advances in Photobiomodulation: Effects on Mesenchymal Stem Cells and their Paracrine Factors
Mesenchymal stem cells (MSCs) have emerged as pivotal tools in biomedical engineering, owing to their remarkable capacity for tissue repair and regeneration. Photobiomodulation (PBM), a non-invasive and safe physical stimulation technique, has demonstrated significant potential in enhancing MSCs’ cellular activity, osteogenic differentiation, and therapeutic efficacy. Despite these promising findings, several challenges hinder the clinical translation of PBM, including the optimization of irradiation parameters to maximize therapeutic outcomes and the standardization of protocols to ensure reproducibility and reliability. This review explores the current advancements in PBM technology and its application in MSC research, with a focus on understanding its mechanisms and therapeutic potential. By delving into the fine-tuning of PBM parameters, including cell factor secretion dynamics, signal transduction pathways, and cell-cell interaction networks, we aim to illuminate how PBM modulates the paracrine functions of MSCs. Additionally, the integration of PBM with biomaterials and engineering technologies presents exciting opportunities for bone tissue engineering and cell therapy. Future research should focus on uncovering the mechanisms by which PBM influences MSC behavior, optimizing its therapeutic parameters, and evaluating its safety and long-term benefits. Such efforts will pave the way for PBM’s seamless integration into clinical applications, including complex bone defect repair, thereby advancing its role in precision medicine. Graphical Abstract
- 10 July 2025
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 21 (7) , 1918-1930
Advances in Photobiomodulation: Effects on Mesenchymal Stem Cells and their Paracrine Factors
Mesenchymal stem cells (MSCs) have emerged as pivotal tools in biomedical engineering, owing to their remarkable capacity for tissue repair and regeneration. Photobiomodulation (PBM), a non-invasive and safe physical stimulation technique, has demonstrated significant potential in enhancing MSCs’ cellular activity, osteogenic differentiation, and therapeutic efficacy. Despite these promising findings, several challenges hinder the clinical translation of PBM, including the optimization of irradiation parameters to maximize therapeutic outcomes and the standardization of protocols to ensure reproducibility and reliability. This review explores the current advancements in PBM technology and its application in MSC research, with a focus on understanding its mechanisms and therapeutic potential. By delving into the fine-tuning of PBM parameters, including cell factor secretion dynamics, signal transduction pathways, and cell-cell interaction networks, we aim to illuminate how PBM modulates the paracrine functions of MSCs. Additionally, the integration of PBM with biomaterials and engineering technologies presents exciting opportunities for bone tissue engineering and cell therapy. Future research should focus on uncovering the mechanisms by which PBM influences MSC behavior, optimizing its therapeutic parameters, and evaluating its safety and long-term benefits. Such efforts will pave the way for PBM’s seamless integration into clinical applications, including complex bone defect repair, thereby advancing its role in precision medicine. Graphical Abstract